Search results for "Cardiovascular events"
Adding colchicine after MI may reduce cardiovascular events
While a trial found that low-dose colchicine reduced cardiovascular events after myocardial infarction (MI) significantly more than placebo, there are unresolved questions about inflammation as a therapeutic target, an accompanying editorial noted.
https://immattersacp.org/weekly/archives/2019/11/26/1.htm
26 Nov 2019
Chelation may reduce mortality, cardiovascular events in diabetics after MI
Chelation reduced cardiovascular disease events in patients with diabetes who had a previous myocardial infarction (MI), a recent study found.
https://immattersacp.org/weekly/archives/2013/11/26/5.htm
26 Nov 2013
Prediabetes: What can doctors call it?
Internists know to screen patients for diabetes, but may be unsure how to manage patients whose blood glucose levels are higher than normal but fall below the cutoff of the disease.
https://immattersacp.org/archives/2017/07/prediabetes-what-can-doctors-call-it.htm
1 Jul 2017
Latest updates on ACP's priorities, initiatives
ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights from our e-newsletter, ACP Internist Weekly.
https://immattersacp.org/archives/2021/07/latest-updates-on-acps-priorities-initiatives.htm
1 Jul 2021
Task Force recommends screening for abnormal blood glucose in overweight, obese adults
The U.S. Preventive Services Task Force now recommends screening for abnormal blood glucose as part of cardiovascular risk assessment in overweight and obese adults ages 40 to 70 years.
https://immattersacp.org/weekly/archives/2015/10/27/1.htm
27 Oct 2015
Cardiovascular safety of febuxostat and allopurinol compared in patients with gout and CVD
In a modified intention-to-treat analysis, the primary end point of first occurrence of cardiovascular death, nonfatal myocardial infarction, nonfatal stroke, or urgent revascularization for unstable angina occurred in 10.8% of patients taking febuxostat and in 10.4% of patients taking allopurinol (hazard ratio, 1.03).
https://immattersacp.org/weekly/archives/2018/03/20/4.htm
20 Mar 2018
Migraine associated with cardiovascular risks
Higher absolute risks of cardiovascular disease were observed among patients with migraine across most outcomes and follow-up periods during 19 years of follow-up.
https://immattersacp.org/weekly/archives/2018/02/06/4.htm
6 Feb 2018
Managing HIV with testing, prevention
Antiretroviral therapy has made an impact in treating HIV, but preexposure prophylaxis has created a huge opportunity in preventing infection, with internists poised to play a role.
https://immattersacp.org/archives/2020/03/managing-hiv-with-testing-prevention.htm
1 Mar 2020
Analyses from SPRINT examine cost-effectiveness, patient-reported outcomes with intensive BP control
The first analysis used a microsimulation model to apply findings from SPRINT to a hypothetical cohort of eligible patients. The second compared patient-reported outcomes from SPRINT in the intensive versus the standard treatment group.
https://immattersacp.org/weekly/archives/2017/08/29/2.htm
29 Aug 2017
The never-ending push-pull of statins
Statins have proven their potential to reduce end-point outcomes, such as death from cardiovascular disease. But the drug class also has some downsides, and the pros and the cons become a close call.
https://immattersacp.org/archives/2017/04/statins.htm
1 Apr 2017